Thymosin Alpha-1 vs TB-500
Same thymic family name, completely different jobs — one governs immune competence, the other drives systemic tissue repair. This comparison covers mechanisms, evidence, and which fits which research goal.
Thymosin Alpha-1
28-amino-acid thymic peptide, master regulator of T-cell function. FDA-approved (Zadaxin) for viral hepatitis in 35+ countries.
Shop Thymosin Alpha-1 →TB-500
Active fragment of Thymosin Beta-4. Systemic tissue remodelling via G-actin sequestration and cell migration, not immune-focused.
Shop TB-500 →Side-by-Side Comparison
| Factor | Thymosin Alpha-1 | TB-500 |
|---|---|---|
| Parent protein | Thymosin Alpha-1 (28 aa) | Thymosin Beta-4 fragment (43 aa parent) |
| Primary mechanism | T-cell maturation, NK cell activation | G-actin sequestration, cell migration |
| System targeted | Immune system | Musculoskeletal / systemic tissue repair |
| Regulatory status | FDA-approved (Zadaxin, hepatitis B/C) | Not FDA-approved, research peptide |
| Molecular weight | 3,108.3 Da | 4,963 Da |
| Common pairing | Chronic infection, cancer adjuvant research | BPC-157 (Wolverine Stack) |
| Best for | Immunodeficiency and antiviral research | Tendon, muscle, and systemic recovery research |
Mechanism Deep Dive
Thymosin Alpha-1 — Immune Master Regulator
Thymosin Alpha-1 is naturally secreted by the thymus and governs T-cell maturation, differentiation, and immune competence. Research covers NK cell and dendritic cell activation, antiviral immune response (hepatitis B/C, COVID-19 adjuvant studies), and cancer immunotherapy support — an entirely immunological research focus.
Shop Thymosin Alpha-1 →TB-500 — Systemic Tissue Repair
TB-500 acts through G-actin sequestration, regulating the actin polymerisation critical for cell migration and wound closure. It promotes angiogenesis via VEGF upregulation and mobilises stem cells to injury sites systemically — a mechanism entirely separate from thymic immune signalling despite the shared naming lineage.
Shop TB-500 →Which Peptide Wins For Each Goal?
Immune restoration / antiviral research
Thymosin Alpha-1
FDA-approved for viral hepatitis and studied extensively for T-cell-mediated immune competence.
Tendon / muscle recovery research
TB-500
Systemic tissue remodelling and cell migration mechanism, commonly paired with BPC-157 in recovery protocols.
Cancer immunotherapy adjuvant research
Thymosin Alpha-1
Well-documented research base as an immune adjuvant alongside chemotherapy and other cancer treatments.
Recovery during concurrent infection
Both together
TB-500 drives repair while Thymosin Alpha-1 supports the immune competence needed to clear concurrent infection or inflammation.
Frequently Asked Questions
What is the difference between Thymosin Alpha-1 and TB-500?
Both are thymosin-family peptides but target entirely different systems. Thymosin Alpha-1 is a master regulator of T-cell-mediated immune function, FDA-approved as Zadaxin for viral hepatitis. TB-500 is the active fragment of Thymosin Beta-4, focused on tissue repair through G-actin sequestration and cell migration — it has no direct immune-modulating role.
Are Thymosin Alpha-1 and TB-500 related?
They share the 'thymosin' name and thymic origin but come from different parent proteins — Thymosin Alpha-1 and Thymosin Beta-4 — with distinct amino acid sequences and completely separate mechanisms. The naming similarity does not imply mechanistic overlap.
Can Thymosin Alpha-1 and TB-500 be researched together?
Yes, particularly in recovery contexts involving infection or immune-compromised healing, where TB-500 drives tissue repair while Thymosin Alpha-1 supports the immune competence needed to resolve concurrent infection or inflammation.
Research use only. All products sold by JA Performance are strictly for laboratory and in vitro research purposes. Not for human consumption, medical use, or veterinary use.